Correlation Between Eliem Therapeutics and Vor Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Vor Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Vor Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Vor Biopharma, you can compare the effects of market volatilities on Eliem Therapeutics and Vor Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Vor Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Vor Biopharma.

Diversification Opportunities for Eliem Therapeutics and Vor Biopharma

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Eliem and Vor is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Vor Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vor Biopharma and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Vor Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vor Biopharma has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Vor Biopharma go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Vor Biopharma

Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.42 times more return on investment than Vor Biopharma. However, Eliem Therapeutics is 1.42 times more volatile than Vor Biopharma. It trades about 0.04 of its potential returns per unit of risk. Vor Biopharma is currently generating about -0.05 per unit of risk. If you would invest  251.00  in Eliem Therapeutics on September 2, 2024 and sell it today you would earn a total of  53.00  from holding Eliem Therapeutics or generate 21.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.19%
ValuesDaily Returns

Eliem Therapeutics  vs.  Vor Biopharma

 Performance 
       Timeline  
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Vor Biopharma 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Vor Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Vor Biopharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Eliem Therapeutics and Vor Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eliem Therapeutics and Vor Biopharma

The main advantage of trading using opposite Eliem Therapeutics and Vor Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Vor Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will offset losses from the drop in Vor Biopharma's long position.
The idea behind Eliem Therapeutics and Vor Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
FinTech Suite
Use AI to screen and filter profitable investment opportunities